Comparison of costs of strategies for measuring levels of human immunodeficiency virus type 1 RNA in plasma by using amplicor and ultra direct assays

Journal of Clinical Microbiology

Volumn 36, Issue 11, 1998, Pages 3369-3371

  Raboud, J M ^a,c   Seminari, E ^b   Rae, S L ^a   Harrigan, P R ^a   Hogg, R S ^a   Conway, B ^a   Sherlock, C ^a   Schechter, M T ^a   O'Shaughnessy, M V ^a   Montaner, J S G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NEVIRAPINE; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ALGORITHM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031720493     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.11.3369-3371.1998     Document Type: Article

References (8)

1. Carpenter, C. C. J., M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, J. S. G. Montaner, D. D. Richman, M. S. Saag, R. T. Schooley, M. A. Thompson, S. Vella, P. G. Yeni, and P. A. Volberding. 1997. Antiretroviral therapy for HIV infection in 1997. Updated recommendation of International AIDS Society-USA panel. JAMA 227:1962-1969.
2. Harris, M., C. Durakovic, S. Rae, J. M. Raboud, S. Fransen, A. Shillington, B. Conway, and J. S. G. Montaner. 1997. A pilot study of IDV, NVP and 3TC in patients with advanced HIV disease, abstr. 234. In Proceedings of the 4th Conference on Retrovirus and Opportunistic Infection. Washington, D.C.
3. Hogg, R. S., S. A. Rhone, B. Yip, C. Sherlock, B. Conway, M. V. O'Shaughnessy, M. T. Schechter, and J. S. G. Montaner. 1998. Antiviral effects of double and triple drug combinations among HIV infected adults: lessons from the implementation of viral load driven antiretroviral therapy. AIDS 12:279-284.
4. Montaner, J. S. G., P. Reiss, D. Cooper, S. Vella, M. Harris, B. Conway, M. A. Wainberg, D. Smith, P. Robinson, D. Hall, M. Myers, and J. M. A. Lange. 1998. A randomised double-blinded trial comparing the immunologic and virologie effect of nevirapine, didanosine and zidovudine combinations among amiretroviral naive, AIDS-free, HIV-infected patients with CD4 counts 200-600/mm3. JAMA 279:930-937.
5. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
6. Mulder, J., R. Resnick, B. Saget, S. Scheibel, S. Herman, H. Payne, R. Harrigan, and S. Kwok. 1997. A rapid and simple method for extracting human immunodeficiency virus type 1 RNA from plasma: enhanced sensitivity. J. Clin. Microbiol. 35:1278-1280.
7. Richman. D. D. 1996. HIV therapeutics. Science 272:1886-1889.
8. Rouleau, D., B. Conway, J. M. Raboud, S. Rae, S. Fransen, A. Shillington, C. Zala, M. V. O'Shaughnessy, and J. S. G. Montaner. 1997. Stavudine (d4T) plus lamivudine (3TC) in advanced HIV disease: a short term pilot study. J. Infect. Dis. 176:1156-1160.